User profiles for Johan Neyts

Johan Neyts

Verified email at rega.kuleuven.be
Cited by 44906

α-Ketoamides as broad-spectrum inhibitors of coronavirus and enterovirus replication: structure-based design, synthesis, and activity assessment

…, P Leyssen, K Lanko, J Neyts… - Journal of medicinal …, 2020 - ACS Publications
The main protease of coronaviruses and the 3C protease of enteroviruses share a similar
active-site architecture and a unique requirement for glutamine in the P1 position of the …

[HTML][HTML] Animal models for COVID-19

…, M Beer, T Brasel, JFW Chan, A García-Sastre, J Neyts… - Nature, 2020 - nature.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the aetiological agent of
coronavirus disease 2019 (COVID-19), an emerging respiratory infection caused by the …

Angiogenesis: regulators and clinical applications

S Liekens, E De Clercq, J Neyts - Biochemical pharmacology, 2001 - Elsevier
1 Angiogenesis is a fundamental process in reproduction and wound healing. Under these
conditions, neovascularization is tightly regulated. Unregulated angiogenesis may lead to …

[HTML][HTML] SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape

…, C Havenar-Daughton, L Piccoli, F Benigni, J Neyts… - Nature, 2021 - nature.com
An ideal therapeutic anti-SARS-CoV-2 antibody would resist viral escape 1 , 2 – 3 , have
activity against diverse sarbecoviruses 4 , 5 , 6 – 7 , and be highly protective through viral …

[PDF][PDF] Spatial proteogenomics reveals distinct and evolutionarily conserved hepatic macrophage niches

…, G Ferrero, V Wittamer, A Willaert, SJF Kaptein, J Neyts… - Cell, 2022 - cell.com
The liver is the largest solid organ in the body, yet it remains incompletely characterized.
Here we present a spatial proteogenomic atlas of the healthy and obese human and murine …

[HTML][HTML] Remdesivir, Molnupiravir and Nirmatrelvir remain active against SARS-CoV-2 Omicron and other variants of concern

…, J Raymenants, E André, P Leyssen, J Neyts… - Antiviral research, 2022 - Elsevier
We assessed the in vitro antiviral activity of remdesivir and its parent nucleoside GS-441524,
molnupiravir and its parent nucleoside EIDD-1931 and the viral protease inhibitor …

Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms

…, A Riva, A Gabrieli, M Galli, MS Pizzuto, J Neyts… - Science, 2020 - science.org
Efficient therapeutic options are needed to control the spread of severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) that has caused more than 922,000 fatalities as of 13 …

Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture

…, BG Van Den Hoogen, J Neyts… - Antimicrobial agents …, 2014 - Am Soc Microbiol
Coronaviruses can cause respiratory and enteric disease in a wide variety of human and
animal hosts. The 2003 outbreak of severe acute respiratory syndrome (SARS) first …

[PDF][PDF] N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2

…, LM Bloyet, F Benigni, E Cameroni, J Neyts… - Cell, 2021 - cell.com
The SARS-CoV-2 spike (S) glycoprotein contains an immunodominant receptor-binding
domain (RBD) targeted by most neutralizing antibodies (Abs) in COVID-19 patient plasma. Little …

In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine

E Keyaerts, L Vijgen, P Maes, J Neyts… - … and biophysical research …, 2004 - Elsevier
We report on chloroquine, a 4-amino-quinoline, as an effective inhibitor of the replication of
the severe acute respiratory syndrome coronavirus (SARS-CoV) in vitro. Chloroquine is a …